Literature DB >> 1401789

Intercostal nerve transfer of the musculocutaneous nerve in avulsed brachial plexus injuries: evaluation of 66 patients.

D C Chuang1, M C Yeh, F C Wei.   

Abstract

Intercostal nerve transfer is a well-established and effective technique for irreparable avulsed brachial plexus injuries. Between 1987 and 1989, 66 patients with brachial plexus injuries were treated by means of intercostal nerve transfer to the musculocutaneous nerve, with or without nerve grafts to obtain elbow flexion. The results were evaluated. Five clinical signs--(1) induction of chest pain by squeezing of biceps, (2) proximal biceps contraction, (3) distal biceps contraction, (4) active elbow flexion against gravity, and (5) active elbow flexion against weight--were identified and used as a guide for functional recovery. The overall success rate with motor function of grade 4 or more was 67%. The motor results were better in 1989 (81%) because of greater familiarity with the anatomy and improved surgical technique. The important factors in obtaining a good result are (1) early exploration (less than 5 months after trauma), (2) use of three intercostal nerves, (3) mixed nerve-to-mixed nerve coaptation, (4) nerve repair without grafts and under no tension, and (5) shoulder stability.

Entities:  

Mesh:

Year:  1992        PMID: 1401789     DOI: 10.1016/0363-5023(92)90451-t

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  10 in total

1.  Nerve transfers for adult traumatic brachial plexus palsy (brachial plexus nerve transfer).

Authors:  Rachel S Rohde; Scott W Wolfe
Journal:  HSS J       Date:  2007-02

2.  Investigation Into the Optimal Number of Intercostal Nerve Transfers for Musculocutaneous Nerve Reinnervation: A Systematic Review.

Authors:  Hyuma A Leland; Beina Azadgoli; Daniel J Gould; Mitchel Seruya
Journal:  Hand (N Y)       Date:  2017-11-29

3.  Useful Functional Outcome Can Be Achieved After Motor Nerve Transfers in Management of the Paralytic Hand. An Observational Study.

Authors:  Asser A Sallam; Mohamed S El-Deeb; Mohamed A Imam
Journal:  HSS J       Date:  2015-08-20

4.  Surgical outcomes following nerve transfers in upper brachial plexus injuries.

Authors:  P S Bhandari; L P Sadhotra; P Bhargava; A S Bath; M K Mukherjee; Tejinder Bhatti; Sanjay Maurya
Journal:  Indian J Plast Surg       Date:  2009-07

5.  Use of intercostal nerves for different target neurotization in brachial plexus reconstruction.

Authors:  Marios G Lykissas; Ioannis P Kostas-Agnantis; Ananstasios V Korompilias; Marios D Vekris; Alexandros E Beris
Journal:  World J Orthop       Date:  2013-07-18

6.  Evaluation of pain measurement practices and opinions of peripheral nerve surgeons.

Authors:  Christine B Novak; Dimitri J Anastakis; Dorcas E Beaton; Joel Katz
Journal:  Hand (N Y)       Date:  2009-02-25

Review 7.  A literature review of intercostal-to-musculocutaneous-nerve transfers in brachial plexus injury patients: Does body mass index influence results in Eastern versus Western countries?

Authors:  Mariano Socolovsky; Miguel Domínguez Paez
Journal:  Surg Neurol Int       Date:  2013-11-27

8.  Virtual Rehabilitation of Elbow Flexion Following Nerve Transfer Reconstruction for Brachial Plexus Injuries Using the Single-Joint Hybrid Assisted Limb.

Authors:  Kazuteru Doi; Dawn Sinn Yii Chia; Yasunori Hattori; Sotetsu Sakamoto
Journal:  J Hand Surg Glob Online       Date:  2022-01-13

9.  FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers.

Authors:  Y Leng; Z Wang; L-K Tsai; P Leeds; E B Fessler; J Wang; D-M Chuang
Journal:  Mol Psychiatry       Date:  2014-01-28       Impact factor: 15.992

10.  Effect of Collateral Sprouting on Donor Nerve Function After Nerve Coaptation: A Study of the Brachial Plexus.

Authors:  Pawel Reichert; Zdzisław Kiełbowicz; Piotr Dzięgiel; Bartosz Puła; Marcin Wrzosek; Aneta Bocheńska; Jerzy Gosk
Journal:  Med Sci Monit       Date:  2016-02-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.